XML 24 R12.htm IDEA: XBRL DOCUMENT
v3.25.1

Debt | 3 Months Ended
--- | ---
Mar. 31, 2025
Debt Disclosure [Abstract] |
Debt | Debt Debt for the Company consists of the following:
| March 31, 2025 |  | December 31, 2024 |  |
(in millions, except percentages) | Amount |  | Rate |  | Amount |  | Rate |  | Maturity Date
2023 Credit Agreement: |  |  |  |  |  |  |  |  |
Term A Facility | $ | 1,085.9 |  |  | (1) |  | $ | 475.0 |  |  | (1) |  | October 10, 2028
Term B Facility | 1,596.0 |  |  | (2) |  | 1,600.0 |  |  | (2) |  | October 24, 2031
Revolver | 481.0 |  |  | (1) |  | — |  |  |  |  | October 10, 2028
2031 Senior Notes | 800.0 |  |  | 3.875% |  | 800.0 |  |  | 3.875% |  | October 15, 2031
2029 Senior Notes | 800.0 |  |  | 4.000% |  | 800.0 |  |  | 4.000% |  | April 15, 2029
Securitized debt | 109.8 |  |  | (3) |  | — |  |  |  |  | October 8, 2026
Finance lease obligations (4) | 96.8 |  |  |  |  | 88.7 |  |  |  |  | Various
Other | 100.4 |  |  |  |  | 80.8 |  |  |  |  | Various
Total debt | 5,069.9 |  |  |  |  | 3,844.5 |  |  |  |  |
Less: Deferred financing costs | 36.9 |  |  |  |  | 34.6 |  |  |  |  |
Total debt, net | 5,033.0 |  |  |  |  | 3,809.9 |  |  |  |  |
Less: Current portion | 112.3 |  |  |  |  | 69.5 |  |  |  |  |
Total long-term debt, net | $ | 4,920.7 |  |  |  |  | $ | 3,740.4 |  |  |  |  |
(1) | Interest at SOFR index plus 10 basis points of credit spread adjustment, plus applicable margin of 1.250% as of March 31, 2025 and December 31, 2024.
(2) | Interest at SOFR index plus applicable margin of 2.500% as of March 31, 2025 and December 31, 2024.
(3) | Interest at one month SOFR index plus 10 basis points of credit spread adjustment, plus 85 basis points.
(4) | New finance lease obligations are a non-cash financing activity.
As of March 31, 2025, the Company was in compliance with all applicable debt covenants. 2023 Credit Agreement On October 10, 2023, the Company entered into the 2023 Credit Agreement with a syndicate of banks. The 2023 Credit Agreement provides for a $1.15 billion revolving credit facility, a $500.0 million term loan facility, and an incremental facility in an aggregate amount of up to the greater of $850.0 million and additional amounts subject to the conditions set forth in the 2023 Credit Agreement, plus the amount of certain prepayments, plus an additional unlimited amount subject to compliance with a maximum consolidated secured leverage ratio test. The 2023 Credit Agreement has a $60.0 million sub-facility for the issuance of letters of credit. On February 6, 2024, the Company and certain other parties thereto entered into an Amendment No. 1 ("Amendment No. 1") to the 2023 Credit Agreement which provided for a $625.0 million Delayed Draw Term A Loan and a $40.0 million increase in availability on the existing revolving loan. This amendment was executed in connection with the Company's financing strategy for the Mattress Firm Acquisition. On October 24, 2024, the Company and certain other parties thereto entered into an Amendment No. 2 ("Amendment No. 2") and an Amendment No. 3 ("Amendment No. 3") to the Company's 2023 Credit Agreement. Amendment No. 2 extended the termination date for $605.0 million of the Delayed Draw Term A Loan commitments until October 24, 2025, among other changes. Amendment No. 3 provided for an incremental Term B Loan in the aggregate principal amount of $1.6 billion. The proceeds of the Term B Loan were funded into escrow, net of an original issue discount, on the closing of Amendment No. 3. On February 5, 2025, upon the consummation of the Mattress Firm Acquisition, the Company borrowed $625.0 million under our Delayed Draw Term A Loan and $679.5 million under the revolving credit facility. In addition, approximately $1,592.0 million of proceeds in respect of the Term B Loan were released from escrow. The proceeds of these financings were collectively used to fund a portion of the cash consideration for the acquisition, the repayment of Mattress Firm's debt and the payment of certain fees and expenses related to the acquisition. The Company had outstanding borrowings of $481.0 million under the revolving credit facility as of March 31, 2025. Total availability under the revolving facility was $708.3 million, after a $0.7 million reduction for outstanding letters of credit, as of March 31, 2025. Securitized Debt The Company and certain of its subsidiaries are party to a securitization transaction with respect to certain accounts receivable due to the Company and certain of its subsidiaries (as amended, the "Accounts Receivable Securitization"). As of March 31, 2025, there was no availability under the Accounts Receivable Securitization. While subject to a $200.0 million overall limit, the availability of revolving loans varies over the course of the year based on the seasonality of the Company's accounts receivable.

X
- References No definition available. + Details
Name: | us-gaap_DebtDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for long-term debt. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 470 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/470/tableOfContent + Details
Name: | us-gaap_LongTermDebtTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration